{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:58:46Z","timestamp":1792677526482,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T00:00:00Z","timestamp":1330387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00401-012-0964-x","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T04:29:40Z","timestamp":1330316980000},"page":"37-50","source":"Crossref","is-referenced-by-count":162,"title":["An antibody with high reactivity for disease-associated \u03b1-synuclein reveals extensive brain pathology"],"prefix":"10.1007","volume":"124","author":[{"given":"Gabor G.","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pikkarainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awad A.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Leisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Verch\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Alafuzoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Budka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Perret-Liaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,28]]},"reference":[{"key":"964_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/nen.0b013e3181633526","volume":"67","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Parkkinen L, Al-Sarraj S et al (2008) Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 67:125\u2013143","journal-title":"J Neuropathol Exp Neurol"},{"key":"964_CR2","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"964_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","volume":"116","author":"TG Beach","year":"2008","unstructured":"Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277\u2013288","journal-title":"Acta Neuropathol"},{"key":"964_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114:231\u2013241","journal-title":"Acta Neuropathol"},{"key":"964_CR5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/nbdi.2000.0286","volume":"7","author":"BC Campbell","year":"2000","unstructured":"Campbell BC, Li QX, Culvenor JG et al (2000) Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Neurobiol Dis 7:192\u2013200","journal-title":"Neurobiol Dis"},{"key":"964_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","volume":"76","author":"BC Campbell","year":"2001","unstructured":"Campbell BC, McLean CA, Culvenor JG et al (2001) The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson\u2019s disease. J Neurochem 76:87\u201396","journal-title":"J Neurochem"},{"key":"964_CR7","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.1074\/jbc.M213128200","volume":"278","author":"S Chandra","year":"2003","unstructured":"Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC (2003) A broken alpha-helix in folded alpha-Synuclein. J Biol Chem 278:15313\u201315318","journal-title":"J Biol Chem"},{"key":"964_CR8","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39:2552\u20132563","journal-title":"Biochemistry"},{"key":"964_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2990.2006.00722.x","volume":"32","author":"E Croisier","year":"2006","unstructured":"Croisier E, MRes DE, Deprez M et al (2006) Comparative study of commercially available anti-alpha-synuclein antibodies. Neuropathol Appl Neurobiol 32:351\u2013356","journal-title":"Neuropathol Appl Neurobiol"},{"key":"964_CR10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","volume":"155","author":"JG Culvenor","year":"1999","unstructured":"Culvenor JG, McLean CA, Cutt S et al (1999) Non-Abeta component of Alzheimer\u2019s disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am J Pathol 155:1173\u20131181","journal-title":"Am J Pathol"},{"key":"964_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","volume":"65","author":"V Deramecourt","year":"2006","unstructured":"Deramecourt V, Bombois S, Maurage CA (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"964_CR12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"DW Dickson","year":"1999","unstructured":"Dickson DW, Liu W, Hardy J et al (1999) Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155:1241\u20131251","journal-title":"Am J Pathol"},{"key":"964_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ana.10279","volume":"52","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205\u2013210","journal-title":"Ann Neurol"},{"key":"964_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20:419\u2013425","journal-title":"FASEB J"},{"key":"964_CR15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","volume":"59","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Jakes R, Goedert M et al (2000) A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson\u2019s disease. J Neurosci Res 59:528\u2013533","journal-title":"J Neurosci Res"},{"key":"964_CR16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501","journal-title":"Nat Rev Neurosci"},{"key":"964_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijbiomac.2007.03.008","volume":"41","author":"SJ Hamodrakas","year":"2007","unstructured":"Hamodrakas SJ, Liappa C, Iconomidou VA (2007) Consensus prediction of amyloidogenic determinants in amyloid fibril-forming proteins. Int J Biol Macromol 41:295\u2013300","journal-title":"Int J Biol Macromol"},{"key":"964_CR18","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1021\/bi048453u","volume":"43","author":"W Hoyer","year":"2004","unstructured":"Hoyer W, Cherny D, Subramaniam V, Jovin TM (2004) Impact of the acidic C-terminal region comprising amino acids 109\u2013140 on alpha-synuclein aggregation in vitro. Biochemistry 43:16233\u201316242","journal-title":"Biochemistry"},{"key":"964_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M et al (1995) The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467\u2013475","journal-title":"Neuron"},{"key":"964_CR20","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L et al (2000) Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci 20:6365\u20136373","journal-title":"J Neurosci"},{"key":"964_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00129039-200609000-00016","volume":"14","author":"T Kauppinen","year":"2006","unstructured":"Kauppinen T, Martikainen P, Alafuzoff I (2006) Human postmortem brain tissue and 2-mm tissue microarrays. Appl Immunohistochem Mol Morphol 14:353\u2013359","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"964_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","volume":"276","author":"AS Kolaskar","year":"1990","unstructured":"Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172\u2013174","journal-title":"FEBS Lett"},{"key":"964_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-010-0658-1","volume":"119","author":"GG Kovacs","year":"2010","unstructured":"Kovacs GG, Botond G, Budka H (2010) Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol 119:389\u2013408","journal-title":"Acta Neuropathol"},{"key":"964_CR24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/exnr.1998.6975","volume":"154","author":"JW Langston","year":"1998","unstructured":"Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA (1998) Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson\u2019s, and Alzheimer\u2019s disease. Exp Neurol 154:684\u2013690","journal-title":"Exp Neurol"},{"key":"964_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2006.03.044","volume":"1089","author":"P Martikainen","year":"2006","unstructured":"Martikainen P, Louhelainen AM, Kauppinen T, Alafuzoff I (2006) Human brain tissue microarrays as a platform to investigate diseases of the nervous system. Brain Res 1089:33\u201343","journal-title":"Brain Res"},{"key":"964_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/0929866043407138","volume":"11","author":"FL Martin","year":"2004","unstructured":"Martin FL, Williamson SJ, Paleologou KE, Allsop D, El-Agnaf OM (2004) Alpha-synuclein and the pathogenesis of Parkinson\u2019s disease. Protein Pept Lett 11:229\u2013237","journal-title":"Protein Pept Lett"},{"key":"964_CR27","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","volume":"277","author":"H Miake","year":"2002","unstructured":"Miake H, Mizusawa H, Iwatsubo T, Hasegawa M (2002) Biochemical characterization of the core structure of alpha-synuclein filaments. J Biol Chem 277:19213\u201319219","journal-title":"J Biol Chem"},{"key":"964_CR28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/prot.21558","volume":"70","author":"M Mihajlovic","year":"2008","unstructured":"Mihajlovic M, Lazaridis T (2008) Membrane-bound structure and energetics of alpha-synuclein. Proteins 70:761\u2013778","journal-title":"Proteins"},{"key":"964_CR29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240","journal-title":"Lancet Neurol"},{"key":"964_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2010.08.010","volume":"192","author":"AL Mougenot","year":"2010","unstructured":"Mougenot AL, Betemps D, Hogeveen KN et al (2010) Production of a monoclonal antibody, against human alpha-synuclein, in a subpopulation of C57BL\/6\u00a0J mice, presenting a deletion of the alpha-synuclein locus. J Neurosci Methods 192:268\u2013276","journal-title":"J Neurosci Methods"},{"key":"964_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-5793(98)00887-4","volume":"433","author":"AA Osman","year":"1998","unstructured":"Osman AA, Uhlig H, Thamm B, Schneider-Mergener J, Mothes T (1998) Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies. FEBS Lett 433:103\u2013107","journal-title":"FEBS Lett"},{"key":"964_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM et al (2009) Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132:1093\u20131101","journal-title":"Brain"},{"key":"964_CR33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/NEN.0b013e3181c6c13d","volume":"69","author":"M Pikkarainen","year":"2010","unstructured":"Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 69:40\u201352","journal-title":"J Neuropathol Exp Neurol"},{"key":"964_CR34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1110\/ps.073181508","volume":"17","author":"RC Rivers","year":"2008","unstructured":"Rivers RC, Kumita JR, Tartaglia GG et al (2008) Molecular determinants of the aggregation behavior of alpha- and beta-synuclein. Protein Sci 17:887\u2013898","journal-title":"Protein Sci"},{"key":"964_CR35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN et al (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"964_CR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)63633-4","volume":"163","author":"DM Sampathu","year":"2003","unstructured":"Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VM (2003) Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies. Am J Pathol 163:91\u2013100","journal-title":"Am J Pathol"},{"key":"964_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143","journal-title":"Acta Neuropathol"},{"key":"964_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron 37:583\u2013595","journal-title":"Neuron"},{"key":"964_CR39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","volume":"68","author":"YJ Song","year":"2009","unstructured":"Song YJ, Halliday GM, Holton JL et al (2009) Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 68:1073\u20131083","journal-title":"J Neuropathol Exp Neurol"},{"key":"964_CR40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M et al (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson\u2019s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172\u2013188","journal-title":"Brain"},{"key":"964_CR41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2005.06.047","volume":"135","author":"S Totterdell","year":"2005","unstructured":"Totterdell S, Meredith GE (2005) Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 135:907\u2013913","journal-title":"Neuroscience"},{"key":"964_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"PH Tu","year":"1998","unstructured":"Tu PH, Galvin JE, Baba M et al (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415\u2013422","journal-title":"Ann Neurol"},{"key":"964_CR43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1006\/bbrc.1994.2816","volume":"205","author":"K Ueda","year":"1994","unstructured":"Ueda K, Saitoh T, Mori H (1994) Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer\u2019s disease amyloid. Biochem Biophys Res Commun 205:1366\u20131372","journal-title":"Biochem Biophys Res Commun"},{"key":"964_CR44","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","volume":"105","author":"M Vilar","year":"2008","unstructured":"Vilar M, Chou HT, Luhrs T et al (2008) The fold of alpha-synuclein fibrils. Proc Natl Acad Sci USA 105:8637\u20138642","journal-title":"Proc Natl Acad Sci USA"},{"key":"964_CR45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","volume":"116","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Duda JE, Giasson BI (2008) Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions. Acta Neuropathol 116:37\u201346","journal-title":"Acta Neuropathol"},{"key":"964_CR46","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr (1996) NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry 35:13709\u201313715","journal-title":"Biochemistry"},{"key":"964_CR47","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK et al (2011) In vivo demonstration that {alpha}-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108:4194\u20134199","journal-title":"Proc Natl Acad Sci USA"},{"key":"964_CR48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","volume":"145","author":"S Yu","year":"2007","unstructured":"Yu S, Li X, Liu G et al (2007) Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539\u2013555","journal-title":"Neuroscience"},{"key":"964_CR49","doi-asserted-by":"crossref","unstructured":"Zhou J, Broe M, Huang Y et al (2011) Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson\u2019s disease. Acta Neuropathol 121:695\u2013704","DOI":"10.1007\/s00401-011-0815-1"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0964-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-0964-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0964-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T11:37:56Z","timestamp":1561376276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-0964-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,28]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-0964-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,28]]}}}